1. Home
  2. BLUW vs ZNTL Comparison

BLUW vs ZNTL Comparison

Compare BLUW & ZNTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BLUW

Blue Water Acquisition Corp. III Class A Ordinary Shares

N/A

Current Price

$10.37

Market Cap

335.2M

Sector

N/A

ML Signal

N/A

Logo Zentalis Pharmaceuticals Inc.

ZNTL

Zentalis Pharmaceuticals Inc.

N/A

Current Price

$3.08

Market Cap

289.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BLUW
ZNTL
Founded
2024
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
335.2M
289.0M
IPO Year
2025
2020

Fundamental Metrics

Financial Performance
Metric
BLUW
ZNTL
Price
$10.37
$3.08
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$6.60
AVG Volume (30 Days)
120.6K
800.4K
Earning Date
01-01-0001
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
18.03
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.96
$1.21
52 Week High
$10.41
$6.95

Technical Indicators

Market Signals
Indicator
BLUW
ZNTL
Relative Strength Index (RSI) 52.70 29.59
Support Level $10.24 $2.09
Resistance Level $10.38 $3.30
Average True Range (ATR) 0.01 0.20
MACD -0.00 -0.05
Stochastic Oscillator 41.00 3.29

Price Performance

Historical Comparison
BLUW
ZNTL

About BLUW Blue Water Acquisition Corp. III Class A Ordinary Shares

Blue Water Acquisition Corp III is a blank check company.

About ZNTL Zentalis Pharmaceuticals Inc.

Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.

Share on Social Networks: